Unknown

Dataset Information

0

Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing.


ABSTRACT: EGFR-mutant lung adenocarcinomas (LUAD) display diverse clinical trajectories and are characterized by rapid but short-lived responses to EGFR tyrosine kinase inhibitors (TKIs). Through sequencing of 79 spatially distinct regions from 16 early stage tumors, we show that despite low mutation burdens, EGFR-mutant Asian LUADs unexpectedly exhibit a complex genomic landscape with frequent and early whole-genome doubling, aneuploidy, and high clonal diversity. Multiple truncal alterations, including TP53 mutations and loss of CDKN2A and RB1, converge on cell cycle dysregulation, with late sector-specific high-amplitude amplifications and deletions that potentially beget drug resistant clones. We highlight the association between genomic architecture and clinical phenotypes, such as co-occurring truncal drivers and primary TKI resistance. Through comparative analysis with published smoking-related LUAD, we postulate that the high intra-tumor heterogeneity observed in Asian EGFR-mutant LUAD may be contributed by an early dominant driver, genomic instability, and low background mutation rates.

SUBMITTER: Nahar R 

PROVIDER: S-EPMC5768770 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

| EGAS00001001736 | EGA
2017-01-01 | S-EPMC5774849 | BioStudies
1000-01-01 | S-EPMC5982809 | BioStudies
2019-01-01 | S-EPMC6491940 | BioStudies
2019-01-01 | S-EPMC6440869 | BioStudies
2020-01-01 | S-EPMC7136154 | BioStudies
2019-01-01 | S-EPMC6454871 | BioStudies
1969-12-31 | S-SCDT-EMM-2018-09856-T | BioStudies
2019-01-01 | S-EPMC6554671 | BioStudies
1000-01-01 | S-EPMC6214980 | BioStudies